Clinical Trial Update: Retinal Neurodegeneration in Type 2 Diabetes as Biomarker for Alzheimer´s Disease

View source ↗

Summary

The study explored retinal neurodegeneration in type 2 diabetes as a potential biomarker for Alzheimer's disease. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Retinal Neurodegeneration, Alzheimer´s Disease | Status: COMPLETED